Asthma : Current Treatments (Therapeutic Strategies in ...)

個数:

Asthma : Current Treatments (Therapeutic Strategies in ...)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 350 p.
  • 言語 ENG
  • 商品コード 9781846920158
  • DDC分類 616.238

Full Description

As the incidence of asthma in the adult population continues to increase, and the age of onset in children to decrease, this condition remains a primary concern not only for specialists in respiratory medicine, but also for physicians in many other fields, when dealing with the asthmatic patient. The range of therapeutic agents now available, and the diversity of targets on which they act, presents the doctor with a variety of options for managing the condition. In this volume, leading international authorities explain the mechanisms of action of the drugs currently in use, and their clinical applications, singly and in combination. "Asthma: Current Treatments" provides physicians with a comprehensive resource that will help them evaluate for themselves the right approach for each of their patients. It will also be of interest to other health professionals involved in the care of patients being treated for this condition.

Contents

Preface; FIRST LINE ANTI-INFLAMMATORY AND BRONCHODILATOR DRUGS; 1. Novel mechanistic aspects of GCS in relation to asthma therapy. I Adcock; 2. Benefit-risk of long-acting [beta]-adrenergic and ultra long-acting [beta]-adrenergic agonists. M Cazzola, J Lotvall, MG Matera; 3. Non-bronchodilator activities of beta2-agonists: enhanced efficacy in the management of asthma? N Hanania; 4. The pros and cons of combination therapy. J Lotvall; NOVEL APPROACHES TO BRONCHODILATION; 5. Controversies on antileukotrienes. S Salvi; 6. Role of PDE4 in asthma. G Currie; 7. Anti-cholinergics in asthma? C Virchow; IMMUNOMODULATION; 8. The new role of anti-IgE therapy in the treatment of asthma. C Oliveri, R Polosa, G D'Amato; 9. Life, death and resurrection of allergen immunotherapy in asthma. R Polosa; 10. Role of CpG DNA in asthma. D Gor, J Kline; 11. Putative role of antimicrobial activity in asthma treatment. P Tarsia, S Aliberti, M Pappalettera, M Zanardelli, F Blasi; SUBPHENOTYPE CENTERED THERAPY; 12. What is new in the management of acute asthma? GJ Rodrigo; 13. Rethinking individualized treatment of asthma. FE Hargreave; 14. Determinants of therapeutic response in asthma: cigarette smoking. M Spears, R Chaudhuri, NC Thomson; Abbreviations; General Index.

最近チェックした商品